glutathione mutations in sclc patients Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes The Era of Antibody Drug
The Era of Antibody Drug Conjugates in Lung Cancer: Trick or Threat? Frontiers Molecular subtypes based on ferroptosis related genes and tumor microenvironment infiltration characterization in small cell lung cancer glutathione mutations in sclc patients Role of Cancer: From Mechanisms to Therapies Deep Clustering Based Metabolic Stratification of Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications Frontiers Therapeutic Potential of Glutamine Pathway in Lung Cancer
Pay in 4 interest-free payments of $6.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



